ConductScience.org, home

Paper32731386

Repurposing Drugs to Fight Hepatic Malaria Parasites.

Fontinha D and 2 others. Molecules, 2020. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Repurposing Drugs to Fight Hepatic Malaria Parasites. Papers, record 32731386. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32731386

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Repurposing Drugs to Fight Hepatic Malaria Parasites.
PubMed
Journal
Molecules
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
1.14
iCite
Revised in PubMed
2021-03-04
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fontinha DDiana
2Moules IIsabel
3Prudêncio MMiguelhttps://orcid.org/0000-0003-1746-6029

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntimalarialsMajor topic
Drug RepositioningMajor topic
LiverMajor topic
MalariaMajor topic
PlasmodiumMajor topic
Animals
Humans

Source PubMed

Download CSV of topics

References227

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115286734Drug repositioning: identifying and developing new uses for existing drugs.Nat Rev Drug Discov2004https://conductscience.org/library/papers/15286734PubMed
23112767Cytostatic effect of DL-alpha-difluoromethylornithine against Plasmodium falciparum and its reversal by diamines and spermidine.Parasitol Res1987https://conductscience.org/library/papers/3112767PubMed
327249674Current therapies and future possibilities for drug development against liver-stage malaria.J Clin Invest2016https://conductscience.org/library/papers/27249674PubMed
48521742Malaria therapy and prophylaxis with cotrifazid, a multiple complex combination consisting of rifampicin + isoniazid + sulfamethoxazole + trimethoprim.Chemotherapy1995https://conductscience.org/library/papers/8521742PubMed
519840874Malaria: targeting parasite and host cell kinomes.Biochim Biophys Acta2010https://conductscience.org/library/papers/19840874PubMed
620338054
Does treatment of intestinal helminth infections influence malaria? Background and methodology of a longitudinal study of clinical, parasitological and immunological parameters in Nangapanda, Flores, Indonesia (ImmunoSPIN Study).
BMC Infect Dis2010https://conductscience.org/library/papers/20338054PubMed
715980379Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors.Antimicrob Agents Chemother2005https://conductscience.org/library/papers/15980379PubMed
825414261Ivermectin as a complementary strategy to kill mosquitoes and stop malaria transmission?Clin Infect Dis2015https://conductscience.org/library/papers/25414261PubMed
920133198Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.Trends Parasitol2010https://conductscience.org/library/papers/20133198PubMed
106413237Plasmodium berghei: inhibition of the sporogonous cycle by alpha-difluoromethylornithine.Exp Parasitol1983https://conductscience.org/library/papers/6413237PubMed
111949136Sensitivity of Plasmodium falciparum in The Gambia to co-trimoxazole.Trans R Soc Trop Med Hyg1991https://conductscience.org/library/papers/1949136PubMed
123105475alpha-Difluoromethylornithine inhibits the first part of exoerythrocytic schizogony of Plasmodium berghei in rodents.Ann Soc Belg Med Trop1986https://conductscience.org/library/papers/3105475PubMed
1316267125Purinoceptors are involved in the induction of an osmolyte permeability in malaria-infected and oxidized human erythrocytes.FASEB J2006https://conductscience.org/library/papers/16267125PubMed
141981663The chemotherapy of rodent malaria. XLV. Reversal of chloroquine resistance in rodent and human Plasmodium by antihistaminic agents.Ann Trop Med Parasitol1990https://conductscience.org/library/papers/1981663PubMed
153097887alpha-Difluoromethylornithine induces protective immunity in mice inoculated with Plasmodium berghei sporozoites.Trans R Soc Trop Med Hyg1986https://conductscience.org/library/papers/3097887PubMed
1630067811Deciphering the targets of retroviral protease inhibitors in Plasmodium berghei.PLoS One2018https://conductscience.org/library/papers/30067811PubMed
1712956942Antimalarial effect of agmatine on Plasmodium berghei K173 strain.Acta Pharmacol Sin2003https://conductscience.org/library/papers/12956942PubMed
1818443130Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum.Antimicrob Agents Chemother2008https://conductscience.org/library/papers/18443130PubMed
1917413699Antimalarial activity of sera from subjects taking HIV protease inhibitors.AIDS2007https://conductscience.org/library/papers/17413699PubMed
2015776390Aspartic proteases of Plasmodium falciparum as the target of HIV-1 protease inhibitors.J Infect Dis2005https://conductscience.org/library/papers/15776390PubMed

See all 227 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
40814068The emerging role of Imatinib in malaria management: a review of evidence and future directions.Trop Dis Travel Med Vaccines2025https://conductscience.org/library/papers/40814068PubMed
40278767Combating Malaria: Targeting the Ubiquitin-Proteasome System to Conquer Drug Resistance.Trop Med Infect Dis2025https://conductscience.org/library/papers/40278767PubMed
39896318Exploration of innovative drug repurposing strategies for combating human protozoan diseases: Advances, challenges, and opportunities.J Pharm Anal2025https://conductscience.org/library/papers/39896318PubMed
39810526Targeting Malaria's Achilles' Heels: A Review of Plasmodium Life Cycle Vulnerabilities for Drug Discovery.Curr Top Med Chem2025https://conductscience.org/library/papers/39810526PubMed
39505355Antiplasmodial and Insecticidal Activities of Third-Generation Ivermectin Hybrids.J Med Chem2024https://conductscience.org/library/papers/39505355PubMed
39352879Repositioning Brusatol as a Transmission Blocker of Malaria Parasites.ACS Infect Dis2024https://conductscience.org/library/papers/39352879PubMed
38639491Novel hydrazone compounds with broad-spectrum antiplasmodial activity and synergistic interactions with antimalarial drugs.Antimicrob Agents Chemother2024https://conductscience.org/library/papers/38639491PubMed
36986868Derivatives of Amaryllidaceae Alkaloid Ambelline as Selective Inhibitors of Hepatic Stage of Plasmodium berghei Infection In Vitro.Pharmaceutics2023https://conductscience.org/library/papers/36986868PubMed
36960081Drug Development Strategies for Malaria: With the Hope for New Antimalarial Drug Discovery-An Update.Adv Med2023https://conductscience.org/library/papers/36960081PubMed
36169491In vitro and in silico assessment of new beta amino ketones with antiplasmodial activity.Rev Soc Bras Med Trop2022https://conductscience.org/library/papers/36169491PubMed
36118020Structural insights into Plasmodium PPIases.Front Cell Infect Microbiol2022https://conductscience.org/library/papers/36118020PubMed
34832911Studies of Potency and Efficacy of an Optimized Artemisinin-Quinoline Hybrid against Multiple Stages of the Plasmodium Life Cycle.Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/34832911PubMed
33921170Drug Repurposing: A Review of Old and New Antibiotics for the Treatment of Malaria: Identifying Antibiotics with a Fast Onset of Antiplasmodial Action.Molecules2021https://conductscience.org/library/papers/33921170PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
DHFR1719PubTator's text mininghttps://conductscience.org/library/genes/1719NCBI Gene
MARVELD2153562PubTator's text mininghttps://conductscience.org/library/genes/153562NCBI Gene
ODC14953PubTator's text mininghttps://conductscience.org/library/genes/4953NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32731386

GET https://conductscience.org/api/papers/v1/32731386/references?page=2